Download PDF
Am J Perinatol 2024; 41(S 01): e2225-e2229
DOI: 10.1055/a-2107-1834
Original Article

Evaluating the Association between Prenatal Care Visits and Adverse Perinatal Outcome in Pregnancies Complicated by Opioid Use Disorder

Elizabeth V. Pinchman 
1   Medical Education, Albany Medical College, Albany, New York
,
Michelle N. Lende
2   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Albany Medical Center, Albany, New York
,
Paul Feustel
3   Department of Neuroscience, Albany Medical College, Albany, New York
,
Tara Lynch 
2   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Albany Medical Center, Albany, New York
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective This study aimed to evaluate the association between number of prenatal care visits and adverse perinatal outcome among pregnant individuals with opioid use disorder (OUD).

Study Design This is a retrospective cohort of singleton, nonanomalous pregnancies complicated by OUD that delivered from January 2015 to July 2020 at our academic medical center. Primary outcome was the presence of composite adverse perinatal outcome, defined as one or more of the following: stillbirth, placental abruption, perinatal death, neonatal respiratory distress syndrome, need for morphine treatment, and hyperbilirubinemia. Logistic and linear regression estimated the association between the number of prenatal care visits and the presence of adverse perinatal outcome. A Mann–Whitney U test evaluated the association between number of prenatal care visits and length of hospital stay for the neonate.

Results A total of 185 patients were identified, of which 35 neonates required morphine treatment for neonatal opioid withdrawal syndrome. During pregnancy, most individuals were treated with buprenorphine 107 (57.8%), whereas 64 (34.6%) received methadone, 13 (7.0%) received no treatment, and 1 (0.5%) received naltrexone. The median number of prenatal care visits was 8 (interquartile range: 4–10). With each additional visit per 10 weeks of gestational age, the risk of adverse perinatal outcome decreased by 38% (95% confidence interval [CI]: 0.451–0.854). The need for neonatal intensive care and hyperbilirubinemia also significantly decreased with additional prenatal visits. Neonatal hospital stay decreased by a median of 2 days (95% CI: 1–4) for individuals who received more than the median of eight prenatal care visits.

Conclusion Pregnant individuals with OUD who attend fewer prenatal care visits experience more adverse perinatal outcome. Future research should focus on barriers to prenatal care and interventions to improve access in this high-risk population.

Key Points

  • Use of prenatal care affects newborn outcomes.

  • More prenatal care shortens neonatal hospital stay.

  • Prenatal care reduces certain adverse outcomes.

Keywords

opioid use disorder - neonatal abstinence syndrome - neonatal opioid withdrawal syndrome - pregnancy - prenatal care


Publication History

Received: 11 December 2022

Accepted: 30 May 2023

Accepted Manuscript online:
07 June 2023

Article published online:
10 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS. Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001-2002 to 2012-2013 national epidemiologic survey on alcohol and related conditions. [published correction appears in JAMA Psychiatry 2017;74(10):1079] JAMA Psychiatry 2017; 74 (05) 445-455
    CrossrefPubMedSearch in Google Scholar
  • 2 Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep 2018; 67 (31) 845-849
    CrossrefPubMedSearch in Google Scholar
  • 3 HCUP Fast Stats - Neonatal abstinence syndrome (NAS) among newborn hospitalizations. Agency for Healthcare Research and Quality (AHRQ); 2019. Accessed May 19, 2022 at: www.hcup-us.ahrq.gov/faststats/nas/nasquery.jsp?setting1=IP
    PubMed
  • 4 Honein MA, Boyle C, Redfield RR. Public health surveillance of prenatal opioid exposure in mothers and infants. Pediatrics 2019; 143 (03) e20183801
    CrossrefPubMedSearch in Google Scholar
  • 5 Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307 (18) 1934-1940
    CrossrefPubMedSearch in Google Scholar
  • 6 Leyenaar JK, Schaefer AP, Wasserman JR, Moen EL, O'Malley AJ, Goodman DC. Infant mortality associated with prenatal opioid exposure. JAMA Pediatr 2021; 175 (07) 706-714
    CrossrefPubMedSearch in Google Scholar
  • 7 Yeoh SL, Eastwood J, Wright IM. et al. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Netw Open 2019; 2 (07) e197025
    CrossrefPubMedSearch in Google Scholar
  • 8 Baldacchino A, Arbuckle K, Petrie DJ, McCowan C. Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis. BMC Psychiatry 2014; 14: 104
    CrossrefPubMedSearch in Google Scholar
  • 9 Baldacchino A, Arbuckle K, Petrie DJ, McCowan C. Erratum: neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis. BMC Psychiatry 2015; 15: 134
    CrossrefPubMedSearch in Google Scholar
  • 10 Konijnenberg C, Sarfi M, Melinder A. Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine. Early Hum Dev 2016; 101: 91-97
    CrossrefPubMedSearch in Google Scholar
  • 11 Osterman MJK, Martin JA. Timing and adequacy of prenatal care in the United States, 2016. Natl Vital Stat Rep 2018; 67 (03) 1-14
    PubMedSearch in Google Scholar
  • 12 Gennaro S, Melnyk BM, OʼConnor C, Gibeau AM, Nadel E. Improving prenatal care for minority women. MCN Am J Matern Child Nurs 2016; 41 (03) 147-153
    CrossrefPubMedSearch in Google Scholar
  • 13 Martins F, Oppolzer D, Santos C, Barroso M, Gallardo E. Opioid use in pregnant women and neonatal abstinence syndrome-a review of the literature. Toxics 2019; 7 (01) 9
    CrossrefPubMedSearch in Google Scholar
  • 14 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. 2013. Accessed June 20, 2023 at: https://doi.org/https://doi.org/10.1176/appi.books.9780890425596
    CrossrefPubMed
  • 15 Zahorodny W, Rom C, Whitney W. et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr 1998; 19 (02) 89-93
    CrossrefPubMedSearch in Google Scholar
  • 16 Curran M, Holt C, Arciero M, Quinlan J, Cox D, Craig A. Proxy Finnegan Component Scores for Eat, Sleep, Console in a cohort of opioid-exposed neonates. Hosp Pediatr 2020; 10 (12) 1053-1058
    CrossrefPubMedSearch in Google Scholar
  • 17 Nagarajan MK, Goodman D. Not just substance use: the critical gap in nutritional interventions for pregnant women with opioid use disorders. Public Health 2020; 180: 114-116
    CrossrefPubMedSearch in Google Scholar
  • 18 Ali MM, Dubenitz J. Suicidal behavior, opioid use disorder, and behavioral health treatment: prevalence and correlates among adults in the United States 2015-2018. J Subst Abuse Treat 2021; 130: 108413
    CrossrefPubMedSearch in Google Scholar
  • 19 Committee opinion no. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol 2017; 130 (02) e81-e94
    CrossrefPubMedSearch in Google Scholar
  • 20 NIDA. Treating opioid use disorder during pregnancy. National Institute on Drug Abuse. Accessed June 5, 2022 at: https://nida.nih.gov/publications/treating-opioid-use-disorder-during-pregnancy
    PubMed
  • 21 Alexander K, Short V, Gannon M, Goyal N, Naegle M, Abatemarco DJ. Identified gaps and opportunities in perinatal healthcare delivery for women in treatment for opioid use disorder. Subst Abus 2021; 42 (04) 552-558
    CrossrefPubMedSearch in Google Scholar
  • 22 Heaman MI, Sword W, Elliott L. et al. Barriers and facilitators related to use of prenatal care by inner-city women: perceptions of health care providers. BMC Pregnancy Childbirth 2015; 15: 2
    CrossrefPubMedSearch in Google Scholar
  • 23 Seghete KLM, Graham AM, Shank TM. et al. Advancing preventive interventions for pregnant women who are opioid using via the integration of addiction and mental health research. Curr Addict Rep 2020; 7 (01) 61-67
    CrossrefPubMedSearch in Google Scholar